| Filed On | Filing |
|---|---|
| 12 Jun 2019 |
8-K/A: Submission of Matters to a Vote of Security Holders
The Company held its Annual Meeting on June 5, 2019. At the Annual Meeting, the following matters were submitted to a vote of stockholders: |
| 28 Jul 2017 |
8-K/A: Financial Statements and Exhibits
Therapy Business Unit of Biotest Pharmaceuticals Corporation |
| 22 Jun 2012 |
8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
Consolidated Statements of Changes in Stockholders' Equity (Deficiency) |
| 24 Apr 2012 |
8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
Consolidated Statements of Changes in Stockholders' Equity (Deficiency) |
| 29 Mar 2012 |
8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
Consolidated Statements of Changes in Stockholders' Equity (Deficiency) |
Loading...